文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

心脏骤停收入重症监护室患者的液体平衡与结局

Fluid balance and outcome in cardiac arrest patients admitted to intensive care unit.
PubMed 文献 · Crit Care · 2025-04-14
一句话结论院外心脏骤停后入住ICU的患者中,液体正平衡与90天死亡独立相关(HR 1.8),作者认为限制性液体策略可能有益。

这项多中心研究于2020年8月至2022年6月连续纳入17个ICU的816例成人院外心脏骤停患者,74%出现液体正平衡,90天存活291/816例(36%)。校正多因素Cox分析显示液体正平衡与死亡相关(HR=1.8 [1.3-2.3],p<0.001),倾向性评分匹配(193对)后HR=1.6 [1.1-2.1],p=0.005,landmark分析结果一致,并呈剂量依赖性关联。液体正平衡组更可能需要肾脏替代治疗(10% vs 2%,p=0.001),前7天最低PaO2/FiO2比值更低(158 vs 180,p<0.001)。作者认为,在进一步数据出来前,限制性液体治疗策略可能对院外心脏骤停后患者有益。

要点

  • 816例成人院外心脏骤停患者中74%出现液体正平衡,90天存活291/816例(36%)。
  • 校正多因素分析液体正平衡与死亡相关:HR=1.8(95%CI 1.3-2.3),p<0.001。
  • 倾向性评分匹配193对后HR=1.6(95%CI 1.1-2.1),p=0.005,landmark分析结果一致。
  • 液体正平衡组肾脏替代治疗需求更高(10% vs 2%,p=0.001),前7天最低PaO2/FiO2比值更低(158 vs 180,p<0.001)。
  • 作者认为,在进一步数据出来前,限制性液体治疗策略可能对院外心脏骤停后患者有益。

适用人群与场景

  • 2020年8月至2022年6月在17个重症监护室连续纳入的成人院外心脏骤停患者。

研究设计与关键结果

  • 多中心研究,连续纳入17个ICU的816例成人院外心脏骤停患者,74%出现液体正平衡,90天存活291/816例(36%)。
  • 主要终点90天生存:校正多因素Cox分析液体正平衡与死亡相关(HR=1.8 [95%CI 1.3-2.3],p<0.001)。
  • 倾向性评分匹配193对患者后,液体正平衡与死亡相关(HR=1.6 [95%CI 1.1-2.1],p=0.005),landmark分析结果一致。
  • 液体平衡与死亡率呈剂量依赖性关联。
  • 液体正平衡组更可能需要肾脏替代治疗(10% vs 2%,p=0.001)。
  • 液体正平衡组前7天最低PaO2/FiO2比值更低(158 vs 180,p<0.001)。

证据类型、等级与局限

  • 证据类型:多中心研究(ClinicalTrial.gov队列AfterROSC-1 NCT04167891,注册于2019年11月13日)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在进一步数据出来前,限制性液体治疗策略可能对院外心脏骤停后患者有益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Although shock following cardiac arrest is common and contributes significantly to mortality, the influence of the modalities used to manage the hemodynamic situation, particularly with regard to fluid balance, remains unclear. We evaluated the association between positive fluid balance and outcome after out-of-hospital cardiac arrest (OHCA).

METHODS: We conducted a multicenter study from August 2020 to June 2022, which consecutively enrolled adult OHCA patients in 17 intensive care units. The primary endpoint was 90-day survival. Multivariate Cox analysis, propensity score matching and landmark analysis were performed, along with several sensitivity analyses.

RESULTS: Of the 816 patients included in our study, 74% had a positive fluid balance, and 291 of 816 patients (36%) were alive at 90-day. A positive fluid balance was associated with mortality after adjusted multivariate analysis (HR = 1.8 [1.3 - 2.3], p < 0.001), after propensity score matching (n = 193 matched patient pairs, HR = 1.6 [1.1 - 2.1], p = 0.005) and after landmark analysis. We reported a dose-dependent association between fluid balance and mortality. Patients with a positive fluid balance were more likely to need renal replacement therapy (10% vs. 2%, p = 0.001) and had a lower minimum PaO2/FiO2 ratio in the first seven days (158 vs. 180, p < 0.001).

CONCLUSIONS: After cardiac arrest, a positive fluid balance is consistently associated with a worse outcome. Pending further data, a restrictive fluid therapy strategy may be beneficial in post-OHCA patients.

TRIAL REGISTRATION: ClinicalTrial.gov cohort AfterROSC-1 NCT04167891 registered November 13th, 2019, ethics committees 2019-A01378-49 and CPP-SMIV 190901.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Renaudier M, Lascarrou JB, Chelly J, et al. Fluid balance and outcome in cardiac arrest patients admitted to intensive care unit. Crit Care. 2025. PMID: 40229890. doi:10.1186/s13054-025-05391-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。